Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 160
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of...

Can a Dietary Intervention Reduce Mercury Toxicity Among Native Communities in Peru?

A state of emergency has been declared in Madre de Dios, Peru due to high levels of mercury (Hg) exposure...

S-glutathionylation reactions in mitochondrial function and disease

This project was an invited review that is currently under minor revision at Frontiers Cellular and Developmental...

Backer Badge Funded